Health Condition 1: L219- Seborrheic dermatitis, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patient with classical signs and symptoms of Darunaka and Dandruff. 2 Patient of Age group between 15 to 50yrs with irrespective of gender. 3 Patient willing to sign and give consent.
Exclusion criteria
Exclusion criteria: 1 Patient with secondary scalp infections. 2 Patient diagnosed with any other disease related to the scalp scalp psoriasis tinea capitis seborrheic dermatitis contact dermatitis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect of Trial Drug on Improvement in the symptoms of Darunaka(Dandruff)Timepoint: 7day,14day,21day | — |
Secondary
| Measure | Time frame |
|---|---|
| Saftey of trial drug and Adverse Drug Reaction Aggravation of symptoms of Darunaka (Dandruff)Timepoint: 7day,14day,21day | — |
Countries
India
Contacts
Sidramappa Danigond Memorial Trusts Ayurvedic Medical College Post Graduation Centre